Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:pathogenesis:microbiota:interaction [03.20.2020] – [Viruses] sallieqhome:pathogenesis:microbiota:interaction [03.20.2020] – [Viruses] sallieq
Line 37: Line 37:
 [[http://www.koreabiomed.com/news/articleView.html?idxno=7428|Treatment guidelines for coronavirus (Korea 2020)]] [[http://www.koreabiomed.com/news/articleView.html?idxno=7428|Treatment guidelines for coronavirus (Korea 2020)]]
  
-[[http://www.koreabiomed.com/news/articleView.html?idxno=7718|Fewer new cases 20/3/2020]]+[[http://www.koreabiomed.com/news/articleView.html?idxno=7718|Fewer new cases 20/3/2020 (Korea) ]] 
 + 
 +current evidence(({{pubmed>long:    32096567}})) 
 + 
 +breakthrough(({{pubmed>long:    32074550}})) 
 + 
 +chloroquine (({{pubmed>long:    32147496}})) 
 + 
 + neuroinvasive potential(({{pubmed>long:    32104915}})) 
 + 
 +Unique epidemiological and clinical features(({{pubmed>long:    32134116}})) 
 + 
 +What we know so far(({{pubmed>long:    32139372}})) 
 + 
 +Presumed Asymptomatic Carrier Transmission(({{pubmed>long:    32083643}})) 
 + 
 +Discovering drugs(({{pubmed>long:    32147628}})) 
 + 
 + 
 +[[https://www.mediterranee-infection.com/wp-content/uploads/2020/03/Hydroxychloroquine_final_DOI_IJAA.pdf|small sample size survey shows hydroxychloroquine treatment is significantly associated with viral load reduction in COVID-19 patients, effect is reinforced by azithromycin.]] 
 ==== Bacteria ==== ==== Bacteria ====
  
home/pathogenesis/microbiota/interaction.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.